Iščem...
Iskalni niz je ali predolg ali pa vsebuje preveč besed.
Prevodi: sl > en
51–54/54
toksikološko preskušanje
51 Prevajalska redakcija
izobraževanje
CELEX: 31990L0167
ker je treba upoštevati predpise Skupnosti o veterinarskih zdravilih in zlasti Direktivo Sveta 81/851/EGS z dne 28. septembra 1981 o približevanju zakonov držav članic o veterinarskih zdravilih [4] in Direktivo Sveta 81/852/EGS z dne 28. septembra 1981 o približevanju zakonov držav članic o analitskih, farmako-toksikoloških in kliničnih standardih ter protokolih o preskušanju veterinarskih zdravil [5], kakor je bila spremenjena z Direktivo 87/20/EGS [6];
Whereas Community rules regarding veterinary medicinal products, and in particular Council Directive 81/851/EEC of 28 September 1981 on the approximation of the laws of Member States relating to veterinary medicinal products (4), and Council Directive 81/852/EEC of 28 September 1981 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of veterinary medicinal products (5), as amended by Directive 87/20/EEC (6), should be taken into account;
52 Prevajalska redakcija
izobraževanje
CELEX: 32001L0083
Raziskovalec se mora seznaniti z zaključki farmakoloških in toksikoloških raziskav in vlagatelj mu mora predložiti vsaj brošuro za raziskovalca, ki sestoji iz vseh pomembnih informacij, ki so bile poznane pred začetkom kliničnega preskušanja, vključno s kemijskimi, farmacevtskimi in biološkimi podatki, toksikološkimi, farmakokinetičnimi in farmakodinamičnimi podatki pri živalih ter rezultati prejšnjih kliničnih preskušanj, z ustreznimi podatki, ki utemeljujejo vrsto, obseg in trajanje predlaganega preskušanja;
The investigator must acquaint himself with the conclusions drawn from the pharmacological and toxicological studies and hence the applicant must provide him at least with the investigator's brochure, consisting of all the relevant information known prior to the onset of a clinical trial including chemical, pharmaceutical and biological data, toxicological, pharmacokinetic and pharmacodynamic data in animals and the results of earlier clinical trials, with adequate data to justify the nature, scale and duration of the proposed trial;
53 Prevajalska redakcija
izobraževanje
CELEX: 31993R2309
ker so pri zdravilih za uporabo v humani medicini merila kakovosti, varnosti in učinkovitosti v znatni meri usklajena z Direktivo Sveta 65/65/EGS z dne 26. januarja 1965 o približevanju določb zakonov ali drugih predpisov, ki se nanašajo na zdravila 1, in z drugo Direktivo Sveta 75/319/EGS z dne 20. maja 1975 o približevanju določb zakonov in drugih predpisov, ki se nanašajo na lastniška zdravila 2, in z Direktivo Sveta 75/318/EGS z dne 20. maja 1975 o približevanju zakonodaje držav članic v zvezi z analiznimi farmakološko-toksikološkimi in kliničnimi standardi in protokoli, ki se nanašajo na preskušanje zdravil za uporabo v veterini 3,
Whereas, in the case of medicinal products for human use, the criteria of quality, safety and efficacy have been extensively harmonized by Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (5), and the Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation and administrative action relating to proprietary medicinal products (6), and by Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of the Member States relating to analytical pharmaco-toxicological and clinical standards and protocols in respect of the testing of medicinal products (6);
54 Prevajalska redakcija
izobraževanje
CELEX: 31999R1308
Od sprejetja Uredbe Sveta (EGS) št. 2377/90 [4] se je zakonodajno okolje za zdravila za uporabo v veterinarska medicini temeljito spremenilo, zlasti zaradi začetka veljavnosti Uredbe Sveta (ES) št. 2309/93 z dne 22. julija o določitvi postopkov Skupnosti za pridobitev dovoljenja za promet in nadzor zdravil za uporabo v humani medicini in zdravil za uporabo v veterinarski medicini in o ustanovitvi Evropske agencije za zdravila [5] ter sprememb, ki jih prinaša Direktiva 93/40/EGS [6] za Direktivo Sveta 81/851/EGS z dne 28. septembra 1981 o približevanju zakonodaje držav članic glede zdravil za uporabo v veterinarski medicini [7] in za Direktivo Sveta 81/852/EGS z dne 28. septembra 1981 o približevanju zakonodaje glede analitičnih, farmako-toksikoloških in kliničnih standardov in protokolov v zvezi s preskušanjem zdravil za uporabo v veterinarski medicini [8].
since the adoption of Council Regulation (EEC) No 2377/90(4), the regulatory environment for veterinary medicinal products has altered radically, in particular as a result of the entry into force of Council Regulation (EC) No 2309/93 of 22 July laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products(5) and of the amendments made by Directive 93/40/EEC(6) to Council Directive 81/851/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to veterinary medicinal products(7), and to Council Directive 81/852/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of veterinary medicinal products(8);
Prevodi: sl > en
51–54/54
toksikološko preskušanje